FluroTech Protects Its Technological Advantage with Patent Application
November 5, 2018
Calgary, Alberta -- FluroTech Ltd. (TEST), ("FluroTech" or the "Company"), is pleased to announce two recently-filed patent applications to which the Company holds exclusive, irrevocable rights for use in the cannabis industry. The patents include an international patent application filed October 31, 2018 pursuant to the Patent Cooperation Treaty ("PCT"), and a national phase entry [...]
Optibrium and University of Nottingham Collaborate on Innovative Teaching Programme
November 5, 2018
Provides students with the opportunity to design new drug-like molecules targeting fibrotic diseases and malaria with cutting-edge drug discovery software CAMBRIDGE and NOTTINGHAM, UK – Optibrium™, a developer of software for drug discovery, today announced it had entered into a collaboration with the University of Nottingham, a pioneering research institution and university. Optibrium’s StarDrop™ software [...]
AMSBIO: Consistent High Quality Cell Line Controls
November 2, 2018
AMSBIO has expanded its range of high quality FFPE cancer cell line controls for immunohistochemistry (IHC), in situ hybridization (ISH) and Next Generation Sequencing (NGS) applications. Variations in FFPE tissue sample quality and experimental setup can lead to misleading results without reliable controls. Traditional cell or tissue-based control specimens often present intra specimen variation, lot-to-lot variations [...]
Thorlabs Licenses Revolutionary Multiphoton Volume Imaging Technique
November 2, 2018
Newton, NJ – Thorlabs announced today that it has signed a licensing agreement with Howard Hughes Medical Institute (HHMI) for exclusive rights to a new bessel beam-based, multiphoton volume imaging technique. The technique was originally developed at HHMI’s Janelia Research Campus in the lab of Dr. Na Ji, who now resides at the University of [...]
November 2, 2018
Today, Bioinformatics Solutions Inc. (BSI) will be releasing PEAKS X within its PEAKS Studio platform, to provide a complete and vendor neutral solution for DDA and DIA discovery proteomics. The latest features added to the software include: • Resolution for Chimeric Spectra • Spectral-Library-Free DIA Support • De Novo Sequencing for DIA Data • Improved [...]
Wilbur Prezzano Elected Chairman of the Board
November 2, 2018
SARASOTA, Fla. -- Roper Technologies, Inc. (NYSE: ROP) announced that its Executive Chairman and former, long-time Chief Executive Officer Brian Jellison passed away today. Mr. Jellison joined Roper as Chief Executive Officer in 2001 and became Chairman of the Board in 2003. Neil Hunn, Roper’s President and Chief Executive Officer, commented: “All of us at Roper are [...]
Agilent Introduces New ICP-MS Water Analyzer Solution
November 2, 2018
Fully integrated solution increases productivity of environmental labs SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today introduced a new turnkey solution for analyzing water quality. The Agilent ICP-MS Water Analyzerenables environmental laboratories to set up and run regulated methods in a matter of days rather than weeks or even months. The new water analyzer package [...]
MEET OUR NEW INTERNATIONAL BUSINESS DEVELOPMENT MANAGER AT CLEANAIR BY BAKER!
November 2, 2018
My name is Thijs van den Dungen, 47 years old and I live in Son en Breugel. On 1 September I started as International Business Development Manager at CleanAir by Baker. For the past 15 years, I have worked as Area Sales Manager and Project Adviser at 2 laboratory designers who are involved in setting [...]
INTRODUCING ELEMENT-D, THE LATEST ADDITION TO THE ELEMENTAL MACHINES PLATFORM
November 1, 2018
CAMBRIDGE, Mass.–Elemental Machines, a provider of data science and Internet of Things (IoT) solutions for technology-based industries, today announces Element-D, the newest addition to its platform. Element-D (Data) is an IoT data collection device that connects OEM instruments to the cloud to automate the collection of scientific data, metadata such as maintenance and calibration records, and [...]
Inscripta Hires Chief Commercial Officer Jason T. Gammack to Bring Gene-Editing Tools to Market
November 1, 2018
Boulder, Colo. – Inscripta™, a leading gene-editing technology company, today announced the addition of Jason T. Gammack as the company’s first chief commercial officer. Gammack, a 25-year veteran of life sciences commercial operations, will leverage his experience at leading biotechnology companies to design and oversee Inscripta’s sales, marketing, business development, and customer support operations. “We are [...]

